More Adalta Ltd. news Adalta Ltd.ASX: 1AD AD-214 pathway to IPF efficacy studies Jul 19, 2021 at 3:25 AM UTC · Issued by Adalta Ltd. As issuedPlain English Adalta Ltd has released a press release. View Attachment
